Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-22-021728

Chief Technology Officer sold 2,627 shares at $26.24 ($68,925)

From the SEC's structured data for this filing

Trades in this filing

HANLY ANN M. · Chief Technology Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-03-30 Sale : show line 1 in the form −2,627 $26.24 $68,925 81,473 D
Open-market sales · 2,627 sh · avg $26.24 · $68,925
Loading xslF345X03/doc4.xml…